Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
The Grant for Fertility Innovation (GFI) supports the advancement of science and innovative technologies in the fertility field. Since 2010 Merck Serono has been awarding grants that total up to 10 million euros to translational research projects that could potentially improve take home baby rate for the benefits of the patients. |
Característiques principals
Researchers from around the world may apply for a grant if they are involved in innovative clinical and translational research projects associated with drugs, processes and/or technologies applied during treatment with assisted reproductive technology, which could potentially provide an improvement in implantation, pregnancy and live birth rate. Applicants must be aware that to be eligible to apply they must have completed a pilot study with positive outcomes in the improvement of implantation, pregnancy and live birth rates. Clinical Trials testing, safety and efficacy of marketed drugs as primary outcomes are not within the scope of GFI grant. We suggest submitting projects investigating on HOW TO REDUCE TIME TO LIVE BIRTH within assisted reproductive technology by: Clinical trials testing, safety and efficacy of marketed drugs as primary outcomes are not within the scope of the grant. |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00. Carol Barnwell: cbarnwell@imim.es Ext.1670 Marta López: mlopez4@imim.es, Ext.: 1576 |
Convocatòria (URL)
http://www2.grantforfertilityinnovation.com/EMDSerono/index.html |
Dotació
Budgets of up to €150,000 |
Documentació
Applicants should submit their completed application form to gfi@emdserono.com |
Arxius
Arxiu |
---|
Grant application form_EMD Serono363_27753.doc |
Grant for Fertility Innovation - What is the GFI_.pdf |